New Antibiotic Now Available for Treatment of Two Serious Lower Respiratory Tract Infections

Article

More than 17 million people in the United States will be affected by two serious respiratory infections, community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis. Of those 17 million, 45,000 will die. Those at greatest risk are older Americans. According to the American Lung Association, pneumonia and flu are the seventh leading cause of death and the leading cause of death by infectious disease in the United States.

There is an increasing need among doctors for new treatment options that remain active against multi-drug resistant strains of Streptococcus pneumoniae (MDRSP). Streptococcus pneumoniae is a common cause of respiratory tract infections and its increasing resistance to commonly-used antibiotics is a major concern for the medical community.

Now there is a new antibiotic available called FACTIVE, giving physicians a greatly needed weapon to fight these two very serious respiratory tract infections. FACTIVE, in the fluoroquinolone class of drugs, offers a short-course therapy for patients that may be "at- risk" for MDRSP or those who have recently received antibiotics, have a compromised immune system or underlying medical conditions such as cardiac or pulmonary disease. FACTIVE was approved by the United States Food and Drug Administration based on clinical trials in nearly 7,000 patients. The Infectious Diseases Society of America cites FACTIVE as the most active antibiotic in the test tube of all fluoroquinolones.

Source: Oscient Pharmaceuticals Corporation

Related Videos
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Infection Control Today's topic of the month: Mental Health
Related Content